Nonanimal Sourced Hyaluronic Acid–Based Dermal Filler Using a Cohesive Polydensified Matrix Technology is Superior to Bovine Collagen in the Correction of Moderate to Severe Nasolabial Folds

皱纹 透明质酸 医学 鼻唇沟 真皮 不利影响 外科 填料(材料) 牙科 软组织 内科学 材料科学 复合材料 病理 解剖 老年学
作者
Rhoda S. Narins,William P. Coleman,Lisa Donofrio,Derek Jones,Corey S. Maas,Gary D. Monheit,Mandeep Kaur,Starr Grundy,Eric J. Pappert,Bhushan Hardas
出处
期刊:Dermatologic Surgery [Lippincott Williams & Wilkins]
卷期号:36 (1): 730-740 被引量:20
标识
DOI:10.1111/j.1524-4725.2010.01553.x
摘要

BACKGROUND Dermal fillers are used to augment wrinkles and folds, and a variety of hyaluronic acid (HA)-based products are available. The non-animal-sourced HA studied was cross-linked using a two-step process and employing cohesive polydensified matrix (CPM) technology. This HA gel (CPMHA) has variable density and viscosity zones for adaptation in the dermis. OBJECTIVE To compare the safety and effectiveness of CPMHA with that of bovine collagen (COL) in the correction of moderate to severe nasolabial folds (NLFs) in a split-face study. METHODS AND MATERIALS One hundred eighteen subjects were randomized to receive CPMHA and COL on contralateral sides of the face. NLF severity was measured using the Wrinkle Severity Rating Scale (WSRS). The initial treatment was evaluated after 2 weeks, and an optional touch-up to optimal cosmetic correction was permitted if needed. Subjects returned every 2 weeks (up to 24 weeks) for evaluation. Safety was assessed using spontaneous adverse event (AE) reporting. RESULTS CPMHA resulted in a significantly greater reduction in the mean change of WSRS than COL at weeks 8 (p=.009), 12 (p<.001), 16 (p<.001), and 24 (p<.001). There were no significant differences between the two groups in the proportion of AEs considered related to the injection site procedure. Most AEs were mild to moderate in severity and resolved within 7 days. CONCLUSION CPMHA was well tolerated and first demonstrated to be noninferior and then superior in terms of effectiveness to COL over 24 weeks for the treatment of NLF, including the primary end point at week 12. Merz Pharmaceuticals, LLC funded this Food and Drug Administration clinical trial. Bhushan Hardas, Mandeep Kaur, Starr Grundy, and Eric Pappert are employees of Merz Pharmaceuticals.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
穆雨发布了新的文献求助10
1秒前
圣人海完成签到,获得积分10
2秒前
tt发布了新的文献求助10
2秒前
2秒前
尉迟姿发布了新的文献求助10
3秒前
KKLUV发布了新的文献求助10
3秒前
xxxpeacey发布了新的文献求助10
3秒前
3秒前
3秒前
ksp完成签到,获得积分10
3秒前
bkagyin的应助被Ann采纳,获得10
3秒前
小时完成签到,获得积分10
3秒前
刘宇发布了新的文献求助10
4秒前
挚友发布了新的文献求助10
5秒前
三分之二发布了新的文献求助10
5秒前
拼搏可冥发布了新的文献求助10
5秒前
所所的应助被无语的若风采纳,获得10
6秒前
传奇3的应助被听话的含羞草采纳,获得10
6秒前
ZLongevity完成签到 ,获得积分10
6秒前
6秒前
6秒前
FashionBoy的应助被任性小霜采纳,获得10
6秒前
zz完成签到,获得积分10
7秒前
Kevin发布了新的文献求助10
7秒前
Tory发布了新的文献求助30
7秒前
无花果的应助被郑丽琴采纳,获得10
9秒前
情怀的应助被雯雯采纳,获得10
9秒前
KKLUV完成签到,获得积分10
10秒前
赘婿的应助被余念难安采纳,获得10
10秒前
所所的应助被dudu采纳,获得10
11秒前
11秒前
12秒前
12秒前
14秒前
啄春泥发布了新的文献求助10
15秒前
CipherSage的应助被crush采纳,获得30
15秒前
无花果的应助被激昂的如柏采纳,获得10
15秒前
Zhixia发布了新的文献求助10
16秒前
王欣荣完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177767
求助须知:如何正确求助?哪些是违规求助? 9568590
关于积分的说明 21799821
捐赠科研通 7772374
什么是DOI,文献DOI怎么找? 3432476
关于科研通互助平台的介绍 2556695
邀请新用户注册赠送积分活动 2478034